Affymax to Present at Citi's 4th Annual Biotech Day.PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. -- Affymax, Inc. (Nasdaq: AFFY) today announced that Paul B. Cleveland, the company's chief financial officer and executive vice president of corporate development, will present at Citi's 4th Annual Biotech Day at 3:20 p.m. ET on April 1, 2009 in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY. A live webcast of the presentations will be available on the investors section of the Company's website at www.affymax.com. A replay will also be available for 30 days following the presentation. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax's product candidate, Hematide[TM], is currently in Phase 3 clinical trials phase 3 clinical trial Phase 3 study. See Phase study. for the treatment of anemia associated with chronic renal failure chronic renal failure Chronic kidney failure Nephrology A slow decline in renal function, which may be 2º to chronic HTN, DM, CHF, SLE, or sickle cell anemia and, if extreme, leads to ESRD, mandating kidney dialysis; an abrupt decline in renal function may be . For additional information, please visit www.affymax.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion